News
ENOBIA PHARMA RECEIVES FDA ORPHAN DRUG DESIGNATION
Enobia Pharma Receives FDA Orphan Drug Designation
TARGEGEN ANNOUNCES INITIATION OF CLINICAL TRIAL
Targegen announces initiation of clinical trial
Enobia Pharma Receives FDA Orphan Drug Designation
Targegen announces initiation of clinical trial